LifeSpark Pharma — Oncology · Pulmonology · Cardiology · Diabetology · Orthopaedic · Neurology · Nutraceutical · OTC — Partner With Us
LIFESPARK Pharma Private Limited

Lifcape 500 mg

Rx — Prescription only Oncology Tablet

Cytotoxic chemotherapy presented as oral tablets.

Composition
Capecitabine
Strength
500 mg
Pack size
1 x 21 Tablet
Therapeutic category
Oncology
Indications
Colorectal Cancer, Breast Cancer, Gastric Cancer, Pancreatic Cancer
Dosage and directions
For oral use. To be prescribed, dosed and administered under the supervision of a qualified oncologist. Refer to the approved pack insert for the full prescribing information.
Marketed by
LifeSpark Pharma Private Limited
Manufactured at WHO-GMP approved partner facilities. The manufacturing plant and licence number are printed on the pack.
Keep out of reach of children. Products to be used as directed. Read the label carefully. Consult your physician. To be sold by retail on the prescription of a registered medical practitioner only.

This page is a summary. The pack insert supplied with the product is the authoritative document; where the two differ, the insert prevails. Experienced a side effect? Report it here.

Enquire about Lifcape 500 mg

Please mention the quantity or the information you need. For side effects, use the pharmacovigilance form instead.

Fields marked * are required.

This form is for business and product information only. To report a side effect or a product complaint, please use the pharmacovigilance form so it reaches the right team.